45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
184,443
Insurances with rates
21
CPT / HCPCS codes
0
Source MRF
Most expensive procedures (gross)
51905029-4639971
$149,422
30237-8900-06 - sipuleucel-T - Susp
Gross
$298,844
51905029-4639971
$89,653
30237-8900-06 - sipuleucel-T - Susp
Gross
$298,844
103958918-4660260
$114,240
69866-1030-05 - autologous cultured chondrocytes 1
Gross
$228,480
103958918-4660260
$68,544
69866-1030-05 - autologous cultured chondrocytes 1
Gross
$228,480
103958919-4660260
$114,240
69866-1030-08 - autologous cultured chondrocytes 1
Gross
$228,480
103958919-4660260
$68,544
69866-1030-08 - autologous cultured chondrocytes 1
Gross
$228,480
95380079-4660257
$89,451
00169-7208-01 - coagulation factor VIIa 8000 mcg (
Gross
$178,903
95380079-4660257
$53,671
00169-7208-01 - coagulation factor VIIa 8000 mcg (
Gross
$178,903
102534551-4660256
$82,290
71336-1001-01 - givosiran 189 mg/mL Soln
Gross
$164,580
102534551-4660256
$49,374
71336-1001-01 - givosiran 189 mg/mL Soln
Gross
$164,580
127538326-4639971
$82,175
00310-4535-30 - tremelimumab actl 20 mg/mL Soln
Gross
$164,350
127538326-4639971
$49,305
00310-4535-30 - tremelimumab actl 20 mg/mL Soln
Gross
$164,350
1279402-4660256
$74,025
00003-2328-22 - ipilimumab Soln
Gross
$148,051
1279402-4660256
$44,415
00003-2328-22 - ipilimumab Soln
Gross
$148,051
101891901-4639971
$67,835
72187-0401-01 - tagraxofusp 1000 mcg/mL Soln
Gross
$135,670
101891901-4639971
$40,701
72187-0401-01 - tagraxofusp 1000 mcg/mL Soln
Gross
$135,670
1286149-4660256
$60,328
54396-0801-01 - pegloticase Soln
Gross
$120,656
1286149-4660256
$36,197
54396-0801-01 - pegloticase Soln
Gross
$120,656
95367892-4660256
$60,328
60809-0801-01 - pegloticase 8 mg/mL Soln
Gross
$120,656
95367892-4660256
$36,197
60809-0801-01 - pegloticase 8 mg/mL Soln
Gross
$120,656
1288223-4660257
$57,712
00169-7050-01 - coagulation factor VIIa REC Inject
Gross
$115,423
1288223-4660257
$34,627
00169-7050-01 - coagulation factor VIIa REC Inject
Gross
$115,423
39888518-4660257
$57,712
00169-7205-01 - coagulation factor VIIa 5000 mcg (
Gross
$115,423
39888518-4660257
$34,627
00169-7205-01 - coagulation factor VIIa 5000 mcg (
Gross
$115,423
101883920-4639971
$55,493
79952-0110-01 - loncastuximab tesirine 10 mg Injec
Gross
$110,986
101883920-4639971
$33,296
79952-0110-01 - loncastuximab tesirine 10 mg Injec
Gross
$110,986
94990000-4660256
$54,695
57894-0061-03 - ustekinumab 90 mg/mL Soln
Gross
$109,390
94990000-4660256
$32,817
57894-0061-03 - ustekinumab 90 mg/mL Soln
Gross
$109,390
1282361-4660256
$53,886
57665-0002-02 - pegaspargase 3750. Soln
Gross
$107,771
1282361-4660256
$32,331
57665-0002-02 - pegaspargase 3750. Soln
Gross
$107,771
1282362-4660256
$53,886
54482-0301-01 - pegaspargase 3750. Soln
Gross
$107,771
1282362-4660256
$32,331
54482-0301-01 - pegaspargase 3750. Soln
Gross
$107,771
99090561-4660256
$53,886
72694-0954-01 - pegaspargase 3,750 IntlUnit(s) / 5
Gross
$107,771
99090561-4660256
$32,331
72694-0954-01 - pegaspargase 3,750 IntlUnit(s) / 5
Gross
$107,771
1287035-4639971
$51,721
76128-0155-75 - porfimer 75. mg REC Injection
Gross
$103,442
1287035-4639971
$31,033
76128-0155-75 - porfimer 75. mg REC Injection
Gross
$103,442
133632825-4639870
$50,000
ABIO-DSC-USE #2358147 PMP SET IMPELLA RP US 11F-US
Gross
$100,000
133632825-4639870
$30,000
ABIO-DSC-USE #2358147 PMP SET IMPELLA RP US 11F-US
Gross
$100,000
115221886-4639870
$50,000
S-TIB PER REVAS ATHR[AKMS]
Gross
$100,000
115221886-4639870
$30,000
S-TIB PER REVAS ATHR[AKMS]
Gross
$100,000
115221888-4639870
$50,000
S-TIB PER REV STN AT[AKMS]
Gross
$100,000
115221888-4639870
$30,000
S-TIB PER REV STN AT[AKMS]
Gross
$100,000
115221894-4639870
$50,000
IC-TRL PERI ATH ILIA[AKMS]
Gross
$100,000
115221894-4639870
$30,000
IC-TRL PERI ATH ILIA[AKMS]
Gross
$100,000
115221924-4639870
$50,000
S-FEM POP STNT ATHR[AKMS]
Gross
$100,000
115221924-4639870
$30,000
S-FEM POP STNT ATHR[AKMS]
Gross
$100,000
96549813-4639870
$50,000
S-FEM POP STNT ATHR - GL 106
Gross
$100,000
96549813-4639870
$30,000
S-FEM POP STNT ATHR - GL 106
Gross
$100,000
96549817-4639870
$50,000
S-TIB PER REVAS ATHR - GL 106
Gross
$100,000
96549817-4639870
$30,000
S-TIB PER REVAS ATHR - GL 106
Gross
$100,000
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 51905029-4639971 | 30237-8900-06 - sipuleucel-T - Susp | $298,844 | $149,422 | — | — | 6 |
| 51905029-4639971 | 30237-8900-06 - sipuleucel-T - Susp | $298,844 | $89,653 | — | — | 12 |
| 103958918-4660260 | 69866-1030-05 - autologous cultured chondrocytes 1 | $228,480 | $114,240 | — | — | 6 |
| 103958918-4660260 | 69866-1030-05 - autologous cultured chondrocytes 1 | $228,480 | $68,544 | — | — | 12 |
| 103958919-4660260 | 69866-1030-08 - autologous cultured chondrocytes 1 | $228,480 | $114,240 | — | — | 6 |
| 103958919-4660260 | 69866-1030-08 - autologous cultured chondrocytes 1 | $228,480 | $68,544 | — | — | 12 |
| 95380079-4660257 | 00169-7208-01 - coagulation factor VIIa 8000 mcg ( | $178,903 | $89,451 | — | — | 6 |
| 95380079-4660257 | 00169-7208-01 - coagulation factor VIIa 8000 mcg ( | $178,903 | $53,671 | — | — | 12 |
| 102534551-4660256 | 71336-1001-01 - givosiran 189 mg/mL Soln | $164,580 | $82,290 | — | — | 6 |
| 102534551-4660256 | 71336-1001-01 - givosiran 189 mg/mL Soln | $164,580 | $49,374 | — | — | 12 |
| 127538326-4639971 | 00310-4535-30 - tremelimumab actl 20 mg/mL Soln | $164,350 | $82,175 | — | — | 6 |
| 127538326-4639971 | 00310-4535-30 - tremelimumab actl 20 mg/mL Soln | $164,350 | $49,305 | — | — | 12 |
| 1279402-4660256 | 00003-2328-22 - ipilimumab Soln | $148,051 | $74,025 | — | — | 6 |
| 1279402-4660256 | 00003-2328-22 - ipilimumab Soln | $148,051 | $44,415 | — | — | 12 |
| 101891901-4639971 | 72187-0401-01 - tagraxofusp 1000 mcg/mL Soln | $135,670 | $67,835 | — | — | 6 |
| 101891901-4639971 | 72187-0401-01 - tagraxofusp 1000 mcg/mL Soln | $135,670 | $40,701 | — | — | 12 |
| 1286149-4660256 | 54396-0801-01 - pegloticase Soln | $120,656 | $60,328 | — | — | 6 |
| 1286149-4660256 | 54396-0801-01 - pegloticase Soln | $120,656 | $36,197 | — | — | 12 |
| 95367892-4660256 | 60809-0801-01 - pegloticase 8 mg/mL Soln | $120,656 | $60,328 | — | — | 6 |
| 95367892-4660256 | 60809-0801-01 - pegloticase 8 mg/mL Soln | $120,656 | $36,197 | — | — | 12 |
| 1288223-4660257 | 00169-7050-01 - coagulation factor VIIa REC Inject | $115,423 | $57,712 | — | — | 6 |
| 1288223-4660257 | 00169-7050-01 - coagulation factor VIIa REC Inject | $115,423 | $34,627 | — | — | 12 |
| 39888518-4660257 | 00169-7205-01 - coagulation factor VIIa 5000 mcg ( | $115,423 | $57,712 | — | — | 6 |
| 39888518-4660257 | 00169-7205-01 - coagulation factor VIIa 5000 mcg ( | $115,423 | $34,627 | — | — | 12 |
| 101883920-4639971 | 79952-0110-01 - loncastuximab tesirine 10 mg Injec | $110,986 | $55,493 | — | — | 6 |
| 101883920-4639971 | 79952-0110-01 - loncastuximab tesirine 10 mg Injec | $110,986 | $33,296 | — | — | 12 |
| 94990000-4660256 | 57894-0061-03 - ustekinumab 90 mg/mL Soln | $109,390 | $54,695 | — | — | 6 |
| 94990000-4660256 | 57894-0061-03 - ustekinumab 90 mg/mL Soln | $109,390 | $32,817 | — | — | 12 |
| 1282361-4660256 | 57665-0002-02 - pegaspargase 3750. Soln | $107,771 | $53,886 | — | — | 6 |
| 1282361-4660256 | 57665-0002-02 - pegaspargase 3750. Soln | $107,771 | $32,331 | — | — | 12 |
| 1282362-4660256 | 54482-0301-01 - pegaspargase 3750. Soln | $107,771 | $53,886 | — | — | 6 |
| 1282362-4660256 | 54482-0301-01 - pegaspargase 3750. Soln | $107,771 | $32,331 | — | — | 12 |
| 99090561-4660256 | 72694-0954-01 - pegaspargase 3,750 IntlUnit(s) / 5 | $107,771 | $53,886 | — | — | 6 |
| 99090561-4660256 | 72694-0954-01 - pegaspargase 3,750 IntlUnit(s) / 5 | $107,771 | $32,331 | — | — | 12 |
| 1287035-4639971 | 76128-0155-75 - porfimer 75. mg REC Injection | $103,442 | $51,721 | — | — | 6 |
| 1287035-4639971 | 76128-0155-75 - porfimer 75. mg REC Injection | $103,442 | $31,033 | — | — | 12 |
| 133632825-4639870 | ABIO-DSC-USE #2358147 PMP SET IMPELLA RP US 11F-US | $100,000 | $50,000 | — | — | 6 |
| 133632825-4639870 | ABIO-DSC-USE #2358147 PMP SET IMPELLA RP US 11F-US | $100,000 | $30,000 | — | — | 12 |
| 115221886-4639870 | S-TIB PER REVAS ATHR[AKMS] | $100,000 | $50,000 | — | — | 6 |
| 115221886-4639870 | S-TIB PER REVAS ATHR[AKMS] | $100,000 | $30,000 | — | — | 12 |
| 115221888-4639870 | S-TIB PER REV STN AT[AKMS] | $100,000 | $50,000 | — | — | 6 |
| 115221888-4639870 | S-TIB PER REV STN AT[AKMS] | $100,000 | $30,000 | — | — | 12 |
| 115221894-4639870 | IC-TRL PERI ATH ILIA[AKMS] | $100,000 | $50,000 | — | — | 6 |
| 115221894-4639870 | IC-TRL PERI ATH ILIA[AKMS] | $100,000 | $30,000 | — | — | 12 |
| 115221924-4639870 | S-FEM POP STNT ATHR[AKMS] | $100,000 | $50,000 | — | — | 6 |
| 115221924-4639870 | S-FEM POP STNT ATHR[AKMS] | $100,000 | $30,000 | — | — | 12 |
| 96549813-4639870 | S-FEM POP STNT ATHR - GL 106 | $100,000 | $50,000 | — | — | 6 |
| 96549813-4639870 | S-FEM POP STNT ATHR - GL 106 | $100,000 | $30,000 | — | — | 12 |
| 96549817-4639870 | S-TIB PER REVAS ATHR - GL 106 | $100,000 | $50,000 | — | — | 6 |
| 96549817-4639870 | S-TIB PER REVAS ATHR - GL 106 | $100,000 | $30,000 | — | — | 12 |
Showing top 50 of 184,443 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.